HALO logo
halo search icon
4572
Carna Biosciences, Inc.

4572 · Carna Biosciences, Inc.

361.00

JPY
1.00 (0.278%)
08/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

JPY7.68B

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 08/10/2026 12:00:00 AM

Price Chart

Description

Carna Biosciences, Inc. engages in the drug discovery business. It operates through the Drug Discovery Support and Drug Discovery and Development segments. The Drug Discovery Support segment provides drug discovery supporting products and services such as kinase protein, profiling services, assay development, crystallography, and cell-based assay services. The Drug Discovery and Development segment develops new medicines for the treatment of cancer and inflammatory diseases using the kinase drug discovery platform called QuickScout. The company was founded on April 10, 2003 and is headquartered in Kobe, Japan.

  • All-Companies
  • Extreme Oversold
  • HALO All

Key Fundamentals

EPS 3 yr Growth

14.60%

EBITDA Margin

-358.30%

Operating Cashflow

-¥2,159m

Free Cash Flow Return

-122.90%

ROIC

-123.50%

Interest Coverage

-39.90

Quick Ratio

6.10

Performance

52 weeks range

Low 200 - 512

Trade Value (12mth)

US$176,165.00

1 week

-16.67%

1 month

-11.76%

YTD

-10.45%

1 year

60%

All time high

6030.00

Additional Data

Shares Outstanding (Fully Diluted)

20m

HALO Sector

Healthcare

Next Company Report Date

05-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

JPY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Kawamura TakeshiIndividual
Toshihiko UeharaIndividual
Kazuo HoritaIndividual
Kohichiro YoshinoIndividual
Yoshimi OgawaIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Carna Biosciences, Inc. (4572:TKS)?
Halo FAQ
The current share price of Carna Biosciences, Inc. (4572:TKS) is JPY¥361.00.
2
What is the 52-week high share price for Carna Biosciences, Inc. (4572:TKS)?
Halo FAQ
The 52-week high share price for Carna Biosciences, Inc. (4572:TKS) is JPY¥512.00.
3
What is the 52-week low share price for Carna Biosciences, Inc. (4572:TKS)?
Halo FAQ
The 52-week low share price for Carna Biosciences, Inc. (4572:TKS) is JPY¥200.00.
4
What is the dividend yield for Carna Biosciences, Inc. (4572:TKS)?
Halo FAQ
Carna Biosciences, Inc. (4572:TKS) does not pay a dividend.
5
What was Carna Biosciences, Inc. (4572:TKS) last dividend payment?
Halo FAQ
Carna Biosciences, Inc. (4572:TKS) does not pay a dividend.
6
What is the franking level for Carna Biosciences, Inc. (4572:TKS)?
Halo FAQ
Carna Biosciences, Inc. (4572:TKS) has a franking level of 0.00%.
7
In which sector is Carna Biosciences, Inc. (4572:TKS) classified?
Halo FAQ
Carna Biosciences, Inc. (4572:TKS) is classified in the Healthcare.